Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Crinetics Pharmaceuticals Inc.

www.crinetics.com

Latest From Crinetics Pharmaceuticals Inc.

Start-Up Previews, October 2013

This Month's Profile Group: Biotechs Share Endocrine Enthusiasm, features profiles of Atterocor, Crinetics Pharmaceuticals, and OctreoPharm Sciences. Plus these Start-Ups Across Health Care: Biom’Up SA, KemPharm, LIM Innovations, Reflectance Medical, and Trino Therapeutics.

BioPharmaceutical Medical Device

Crinetics Pharmaceuticals Inc.

The founders of Crinetics Pharmaceuticals Inc. aim to treat endocrine-related diseases and cancers with novel molecules that target peptide hormone receptors. It has been working intensively to apply the concept of biased agonism to the large and popular class of drug targets known as G-protein coupled receptors; it will initially seek to develop a treatment for acromegaly.

BioPharmaceutical

Biotechs Share Endocrine Enthusiasm

Start-ups developing new drugs for rare cancers and other disorders characterized by excessive hormone production know successful treatments are likely to eventually find larger markets. Profiles of Atterocor, Crinetics Pharmaceuticals, and OctreoPharm Sciences.

BioPharmaceutical

Selected Start-Ups (02/2010)

In Vivo briefly describes these recently founded companies: Adenios, Amedrix, Cardialen, Crinetics Pharmaceuticals, Janisys and VitaPath Genetics.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Crinetics Pharmaceuticals Inc.
  • Senior Management
  • R. Scott Struthers, PhD, CSO
    Michael G Wood, VP, Corp. Dev. & Operations
    Yun-Fei Zhu, PhD, VP, Chemistry
    Marc Wilson
  • Contact Info
  • Crinetics Pharmaceuticals Inc.
    Phone: (858) 450-6464
    6197 Cornerstone Ct., Ste. 111
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register